GlassScriptPhysician profile
Syed Abbas
NPI 1154611929
$17,589.80
in general payments reported to CMS, 2019-2025
20 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,730 · 2020: $315 · 2022: $9,726 · 2023: $1,765 · 2024: $738 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,328 · Travel and Lodging: $1,607 · Long Term Medical Supply Or Device Loan: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.17 |
| Travel and Lodging | $1,607.43 |
| Long Term Medical Supply Or Device Loan | $882.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,210.76 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,645.66 | 2023-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $915.46 | 2023-2025 | Acell, Micromatrix, Integra |
| Medical Device Business Services, INC. | $541.23 | 2019 | |
| Becton, Dickinson and Company | $208.73 | 2023-2024 | Phasix Mesh, Bard 3dmax Mesh |
| Boston Scientific Corporation | $197.26 | 2022-2025 | Watchman, Spyglass Discover |
| Biom'Up France Sas | $179.17 | 2020 | |
| Covidien LP | $136.66 | 2019-2020 | |
| Tela Bio, INC. | $129.56 | 2022-2024 | Ovitex 2s |
| Stryker Corporation | $95.28 | 2020 | |
| Innovation Technologies INC | $69.99 | 2025 | Irrisept |
| Otsuka America Pharmaceutical, INC. | $51.84 | 2019-2020 | |
| Medtronic, INC. | $32.15 | 2022 | |
| Progenics Pharmaceuticals, INC. | $27.70 | 2025 | |
| Polynovo North America LLC | $26.63 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.47 | 2024 | Echelon Circular |
| Takeda Pharmaceuticals U.S.A., INC. | $25.47 | 2023 | Gattex |
| Abbvie INC. | $25.28 | 2025 | |
| W. L. Gore & Associates, INC. | $24.88 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Convatec INC. | $19.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.